107 related articles for article (PubMed ID: 27860405)
1. Flow-cytometric screening of aggregation-inhibitors using a fluorescence-assisted intracellular method.
Lindberg H; Sandersjöö L; Meister SW; Uhlén M; Löfblom J; Ståhl S
Biotechnol J; 2017 Jan; 12(1):. PubMed ID: 27860405
[TBL] [Abstract][Full Text] [Related]
2. A truncated and dimeric format of an Affibody library on bacteria enables FACS-mediated isolation of amyloid-beta aggregation inhibitors with subnanomolar affinity.
Lindberg H; Härd T; Löfblom J; Ståhl S
Biotechnol J; 2015 Sep; 10(11):1707-18. PubMed ID: 26184787
[TBL] [Abstract][Full Text] [Related]
3. A plant cell-based system that predicts aβ42 misfolding: potential as a drug discovery tool for Alzheimer's disease.
Zhao T; Zeng Y; Kermode AR
Mol Genet Metab; 2012 Nov; 107(3):571-9. PubMed ID: 22944366
[TBL] [Abstract][Full Text] [Related]
4. Discovery of amyloid-beta aggregation inhibitors using an engineered assay for intracellular protein folding and solubility.
Lee LL; Ha H; Chang YT; DeLisa MP
Protein Sci; 2009 Feb; 18(2):277-86. PubMed ID: 19177561
[TBL] [Abstract][Full Text] [Related]
5. Protein aggregation propensity is a crucial determinant of intracellular inclusion formation and quality control degradation.
Villar-Piqué A; Ventura S
Biochim Biophys Acta; 2013 Dec; 1833(12):2714-2724. PubMed ID: 23856334
[TBL] [Abstract][Full Text] [Related]
6. A fast and specific method to screen for intracellular amyloid inhibitors using bacterial model systems.
Navarro S; Carija A; Muñoz-Torrero D; Ventura S
Eur J Med Chem; 2016 Oct; 121():785-792. PubMed ID: 26608003
[TBL] [Abstract][Full Text] [Related]
7. A high-throughput screen for compounds that inhibit aggregation of the Alzheimer's peptide.
Kim W; Kim Y; Min J; Kim DJ; Chang YT; Hecht MH
ACS Chem Biol; 2006 Aug; 1(7):461-9. PubMed ID: 17168524
[TBL] [Abstract][Full Text] [Related]
8. An engineered autotransporter-based surface expression vector enables efficient display of Affibody molecules on OmpT-negative E. coli as well as protease-mediated secretion in OmpT-positive strains.
Fleetwood F; Andersson KG; Ståhl S; Löfblom J
Microb Cell Fact; 2014 Dec; 13():179. PubMed ID: 25547008
[TBL] [Abstract][Full Text] [Related]
9. Critique of the use of fluorescence-based reporters in Escherichia coli as a screening tool for the identification of peptide inhibitors of Aβ42 aggregation.
Wright O; Zhang L; Liu Y; Yoshimi T; Zheng Y; Tunnacliffe A
J Pept Sci; 2013 Feb; 19(2):74-83. PubMed ID: 23255255
[TBL] [Abstract][Full Text] [Related]
10. Engineered non-fluorescent Affibody molecules facilitate studies of the amyloid-beta (Aβ) peptide in monomeric form: low pH was found to reduce Aβ/Cu(II) binding affinity.
Lindgren J; Segerfeldt P; Sholts SB; Gräslund A; Karlström AE; Wärmländer SK
J Inorg Biochem; 2013 Mar; 120():18-23. PubMed ID: 23262458
[TBL] [Abstract][Full Text] [Related]
11. Linking amyloid protein aggregation and yeast survival.
Morell M; de Groot NS; Vendrell J; Avilés FX; Ventura S
Mol Biosyst; 2011 Apr; 7(4):1121-8. PubMed ID: 21240401
[TBL] [Abstract][Full Text] [Related]
12. General Aggregation-Induced Emission Probes for Amyloid Inhibitors with Dual Inhibition Capacity against Amyloid β-Protein and α-Synuclein.
Jia L; Wang W; Yan Y; Hu R; Sang J; Zhao W; Wang Y; Wei W; Cui W; Yang G; Lu F; Zheng J; Liu F
ACS Appl Mater Interfaces; 2020 Jul; 12(28):31182-31194. PubMed ID: 32584021
[TBL] [Abstract][Full Text] [Related]
13. Recombinant amyloid beta-peptide production by coexpression with an affibody ligand.
Macao B; Hoyer W; Sandberg A; Brorsson AC; Dobson CM; Härd T
BMC Biotechnol; 2008 Oct; 8():82. PubMed ID: 18973685
[TBL] [Abstract][Full Text] [Related]
14. Improvement of the green fluorescent protein reporter system in Leishmania spp. for the in vitro and in vivo screening of antileishmanial drugs.
Pulido SA; Muñoz DL; Restrepo AM; Mesa CV; Alzate JF; Vélez ID; Robledo SM
Acta Trop; 2012 Apr; 122(1):36-45. PubMed ID: 22155571
[TBL] [Abstract][Full Text] [Related]
15. Directed evolution of the 3C protease from coxsackievirus using a novel fluorescence-assisted intracellular method.
Meister SW; Hendrikse NM; Löfblom J
Biol Chem; 2019 Feb; 400(3):405-415. PubMed ID: 30521472
[TBL] [Abstract][Full Text] [Related]
16. A Fragment-Based Method of Creating Small-Molecule Libraries to Target the Aggregation of Intrinsically Disordered Proteins.
Joshi P; Chia S; Habchi J; Knowles TP; Dobson CM; Vendruscolo M
ACS Comb Sci; 2016 Mar; 18(3):144-53. PubMed ID: 26923286
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric analysis of E. coli on agar plates: implications for recombinant protein production.
Wyre C; Overton TW
Biotechnol Lett; 2014 Jul; 36(7):1485-94. PubMed ID: 24652548
[TBL] [Abstract][Full Text] [Related]
18. In vivo amyloid aggregation kinetics tracked by time-lapse confocal microscopy in real-time.
Villar-Piqué A; Espargaró A; Ventura S; Sabate R
Biotechnol J; 2016 Jan; 11(1):172-7. PubMed ID: 26580000
[TBL] [Abstract][Full Text] [Related]
19. Curcumin inhibits aggregation of alpha-synuclein.
Pandey N; Strider J; Nolan WC; Yan SX; Galvin JE
Acta Neuropathol; 2008 Apr; 115(4):479-89. PubMed ID: 18189141
[TBL] [Abstract][Full Text] [Related]
20. Towards multiparametric fluorescent imaging of amyloid formation: studies of a YFP model of alpha-synuclein aggregation.
van Ham TJ; Esposito A; Kumita JR; Hsu ST; Kaminski Schierle GS; Kaminski CF; Dobson CM; Nollen EA; Bertoncini CW
J Mol Biol; 2010 Jan; 395(3):627-42. PubMed ID: 19891973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
